Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
9.25 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.25 | 14514962 11752688 15322242 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.55 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.55 | 17638652 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.57 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.92 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.12 | 17306315 16712894 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.73 | 15955085 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
9.12 | 17963324 15504547 16511603 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
9.12 | 11748828 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.16 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
4.97 | 17286800 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.97 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.38 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.56 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.41 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.41 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.01 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.85 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.56 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.43 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
3.85 | 16818667 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.85 | 16675129 14630087 12948864 17018787 17289903 19861407 18497071 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
3.85 | 19217205 18357371 15136595 16595493 18608205 16110121 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
3.85 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
3.85 | 15562024 17614352 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.85 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
3.85 | 16166294 16873071 16443354 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.78 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.66 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.89 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.56 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.56 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.38 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.76 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
6.76 | 17088986 16799960 17971768 17045692 18930000 16332177 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.76 | 15276417 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
6.76 | 1917145 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
3.27 | 16247446 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.07 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
7.79 | 17066447 16757204 16280240 18986760 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.79 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.79 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.44 | 18670907 16120746 18850075 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.17 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.76 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
11.76 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
11.76 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.78 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.38 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.94 | 12621046 16354765 15668235 8697196 15340226 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.94 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.88 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.25 | 18772588 16340194 17287894 16510598 17016597 17725105 17172411 15001691 17018589 17169374 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.00 | 17016601 18802399 18288408 18509181 15289873 16524972 16391804 17454858 18949393 20501625 18448328 17695437 16282729 16331619 15148649 16303861 17594712 17255274 14970324 17094418 18383874 17401013 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
5.59 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
5.59 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.59 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
5.59 | 14991402 10589399 9224671 17551590 9664655 9211117 8800419 16925845 9125849 9142499 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.37 | 19747007 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.99 | 16733453 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.29 | 20191521 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.54 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.67 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
4.20 | 18186108 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.20 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.86 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.51 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.68 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.68 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.94 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.71 | 19148513 18566989 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.71 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
16.12 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
16.12 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
16.12 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.62 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.62 | 17638652 16337965 16785472 16481741 15173087 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
9.18 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
9.18 | 16938888 9664655 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.63 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.21 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.21 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.87 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.09 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.92 | 16145905 |
MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
5.23 | 19446573 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.81 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.32 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
8.10 | 18337622 15102660 15162350 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
8.10 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.38 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.76 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.76 | 14991402 9664655 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.48 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.07 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.25 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.27 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.97 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.26 | 15340226 18606429 8697196 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.32 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.74 | 16778211 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.95 | 18850075 18670907 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.58 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.08 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.20 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.20 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.05 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.94 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.40 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.40 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.36 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.36 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.88 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
7.88 | 16985049 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.25 | 9562676 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.83 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.84 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.10 | 16294345 17596541 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.24 | 16935935 17712046 16823087 16140955 19035177 9834237 17107899 16766008 19225113 17368321 17339181 12679006 17294898 15748426 19029980 17506722 16788101 17217047 16891316 16331271 19075265 17649720 19642359 17361223 17301526 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.41 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.77 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.52 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.52 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.52 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
7.72 | 17045692 15113037 16603448 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.72 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.72 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.19 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.26 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.24 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
5.00 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
5.00 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
5.00 | 16712894 17306315 15276417 17077188 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
5.00 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.99 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
4.05 | 17352296 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
5.32 | 11161223 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
10.59 | 19196723 19196722 15591091 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
10.59 | 11408345 11807958 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
10.59 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.70 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.83 | 17453147 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.41 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.41 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.60 | 16940565 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.74 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.47 | 17488658 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
5.00 | 18186108 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.15 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.13 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.39 | 16810080 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
8.70 | 18239605 18600527 16928823 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.70 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.70 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.84 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
5.00 | 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.93 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
17.31 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
17.31 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
17.31 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
12.79 | 18186108 10525206 11749123 19446573 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
12.79 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
12.79 | 9142499 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.53 | 16436463 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
15.42 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
15.42 | 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
15.42 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
15.42 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
15.42 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.02 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.49 | 19003803 15113037 16500647 16929163 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.49 | 15976015 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.47 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.72 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.38 | 11399792 11896295 11222880 11118676 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.02 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.56 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.56 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.56 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.75 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.47 | 17410198 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.99 | 16723453 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.14 | 16160472 18286688 18722050 15538739 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.89 | 17352296 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.00 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.25 | 16116481 16283617 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.90 | 18045962 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.79 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.79 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.79 | 16467112 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.47 | 16503802 15862959 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.90 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.54 | 17498489 18396642 16424979 17172411 15786421 16951190 17522103 19084572 18567086 19015929 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.54 | 17261132 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.20 | 9562676 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.12 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.13 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.90 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
10.27 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
10.27 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.31 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.55 | 11723127 16712894 16452187 17306315 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
16.65 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
16.65 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
16.65 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.83 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.62 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.81 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.22 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.47 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.09 | 16287080 |